Invention Grant
- Patent Title: Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (IPCV)
-
Application No.: US16764718Application Date: 2018-11-16
-
Publication No.: US11596667B2Publication Date: 2023-03-07
- Inventor: Kourous Rezaei
- Applicant: IVERIC bio, Inc.
- Applicant Address: US NJ Parisppany
- Assignee: IVERIC bio, Inc.
- Current Assignee: IVERIC bio, Inc.
- Current Assignee Address: US NJ Parisppany
- Agency: Haug Partners LLP
- Agent Jon E. Gordon
- International Application: PCT/US2018/061459 WO 20181116
- International Announcement: WO2019/099786 WO 20190523
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K31/4709 ; A61K31/7105 ; A61K45/06 ; C07K16/18 ; A61P27/02 ; A61P27/06
Abstract:
A method for treating or preventing idiopathic polypoidal choroidal vasculopathy is provided comprising intravitreal injections of Zimura™ (or another anti-C5 agent) and Eylea® (or another VEGF antagonist).
Public/Granted literature
- US20210169975A1 A METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) Public/Granted day:2021-06-10
Information query
IPC分类:
